JP2005503762A5 - - Google Patents

Download PDF

Info

Publication number
JP2005503762A5
JP2005503762A5 JP2002561074A JP2002561074A JP2005503762A5 JP 2005503762 A5 JP2005503762 A5 JP 2005503762A5 JP 2002561074 A JP2002561074 A JP 2002561074A JP 2002561074 A JP2002561074 A JP 2002561074A JP 2005503762 A5 JP2005503762 A5 JP 2005503762A5
Authority
JP
Japan
Prior art keywords
hybridization buffer
molecular weight
dextran sulfate
daltons
vol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002561074A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503762A (ja
Filing date
Publication date
Priority claimed from US09/772,123 external-priority patent/US6656685B2/en
Application filed filed Critical
Publication of JP2005503762A publication Critical patent/JP2005503762A/ja
Publication of JP2005503762A5 publication Critical patent/JP2005503762A5/ja
Pending legal-status Critical Current

Links

JP2002561074A 2001-01-29 2002-01-29 低分子量デキストラン硫酸を使用するハイブリダイゼーション緩衝液およびそれらの使用方法 Pending JP2005503762A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/772,123 US6656685B2 (en) 2001-01-29 2001-01-29 Hybridization buffers using low molecular weight dextran sulfate and methods for their use
PCT/US2002/002642 WO2002061139A2 (en) 2001-01-29 2002-01-29 Hybridization buffers using low molecular weight dextran sulfate and methods for their use

Publications (2)

Publication Number Publication Date
JP2005503762A JP2005503762A (ja) 2005-02-10
JP2005503762A5 true JP2005503762A5 (enExample) 2005-12-22

Family

ID=25093987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002561074A Pending JP2005503762A (ja) 2001-01-29 2002-01-29 低分子量デキストラン硫酸を使用するハイブリダイゼーション緩衝液およびそれらの使用方法

Country Status (8)

Country Link
US (2) US6656685B2 (enExample)
EP (1) EP1356116B1 (enExample)
JP (1) JP2005503762A (enExample)
AT (1) ATE361995T1 (enExample)
AU (1) AU2002240180B2 (enExample)
CA (1) CA2434854A1 (enExample)
DE (1) DE60220018T2 (enExample)
WO (1) WO2002061139A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933117B2 (en) * 2001-04-30 2005-08-23 Ventana Medical Systems, Inc. Reagents and methods for automated hybridization
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
DE102004028303A1 (de) * 2004-06-11 2005-12-29 Roche Diagnostics Gmbh Verfahren und Vorrichtung zum Nachweis von Analyten
US8568982B2 (en) * 2006-08-09 2013-10-29 National University Of Singapore Methods of nucleic acid synthesis using particular crowding agents and concentrations
CA3125026C (en) 2006-11-01 2023-04-04 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
DK2167963T3 (da) 2007-05-23 2019-06-24 Ventana Med Syst Inc Polymerbærere til immunhistokemi og in situ-hybridisering
EP2285982B1 (en) 2008-05-27 2018-04-11 Dako Denmark A/S Compositions and methods for detection of chromosomal aberrations with novel hybridization buffers
US8703490B2 (en) 2008-06-05 2014-04-22 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
EP2401395A1 (en) 2009-02-26 2012-01-04 Dako Denmark A/S Compositions and methods for rna hybridization applications
WO2011057017A1 (en) * 2009-11-06 2011-05-12 Bend Research, Inc. Aqueous nanoparticle suspensions for use in drug discovery
SG10201601853XA (en) 2011-03-11 2016-04-28 Univ Singapore Pericyte progenitors from peripheral blood
EP2761028A1 (en) * 2011-09-30 2014-08-06 Dako Denmark A/S Hybridization compositions and methods using formamide
EP3252173A1 (en) 2011-10-21 2017-12-06 Dako Denmark A/S Hybridization compositions and methods
US10837879B2 (en) * 2011-11-02 2020-11-17 Complete Genomics, Inc. Treatment for stabilizing nucleic acid arrays
EP3133166B2 (de) * 2015-08-21 2023-01-11 42 life sciences GmbH & Co. KG Zusammensetzung und verfahren zur hybridisierung
EP3351263A1 (en) 2017-01-20 2018-07-25 Universitätsklinikum Hamburg-Eppendorf Pharmaceutical preparation for treating or preventing tissue adhesion
MX2020001913A (es) 2017-08-18 2020-09-07 Neutrolis Inc Enzimas dnasa modificadas y uso en terapia.
EP3837381A1 (en) * 2018-08-15 2021-06-23 Illumina, Inc. Compositions and methods for improving library enrichment
US11058724B2 (en) 2018-10-08 2021-07-13 Neutrolis, Inc. Methods of using DNASE1-like 3 in therapy
US10988746B2 (en) 2018-10-08 2021-04-27 Neutrolis, Inc. Manufacturing and engineering of DNASE enzymes for therapy
BR112021006737A2 (pt) * 2018-10-08 2021-07-13 Neutrolis, Inc. engenharia de enzimas dnase para fabricação e terapia
US11352613B2 (en) 2019-02-04 2022-06-07 Neutrolis, Inc. Engineered human extracellular DNASE enzymes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302204A (en) * 1979-07-02 1981-11-24 The Board Of Trustees Of Leland Stanford Junior University Transfer and detection of nucleic acids
US4689294A (en) 1984-11-19 1987-08-25 Miles Laboratories, Inc. Enhancement of hybridization of nucleic acids by anionic polymers
US5985549A (en) 1985-10-22 1999-11-16 University Of Massachusetts Non-isotopic in-situ hybridization method for detection of nucleic acids
US5447841A (en) * 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US4886741A (en) * 1987-12-09 1989-12-12 Microprobe Corporation Use of volume exclusion agents for the enhancement of in situ hybridization
US5273905A (en) * 1991-02-22 1993-12-28 Amoco Corporation Processing of slide mounted material
US5750340A (en) 1995-04-07 1998-05-12 University Of New Mexico In situ hybridization solution and process
US6127188A (en) * 1995-10-06 2000-10-03 Mj Research, Inc. Method and apparatus for controlling evaporation in histological procedures
US5763185A (en) * 1996-12-30 1998-06-09 Becton Dickinson And Company Method for reducing inhibitors of nucleic acid hybridization
CA2321836C (en) * 1998-02-27 2004-09-28 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
US6855552B2 (en) * 1998-09-03 2005-02-15 Ventana Medical Systems Automated immunohistochemical and in situ hybridization assay formulations

Similar Documents

Publication Publication Date Title
JP2005503762A5 (enExample)
JP2003503340A5 (enExample)
JP2003519099A5 (enExample)
TW200800086A (en) Shelving system
EP2077283A4 (en) ETHYLENE COPOLYMER, COPOLYMER COMPOSITION, AND METHOD OF MANUFACTURE
EP2813511A3 (en) Ferric organic compounds, uses thereof and methods of making same
EP2740465A3 (en) Antiperspirant active compositions having SEC chomatogram exhibiting high SEC peak 4 intensity
EP2039804A3 (en) Use of quaternary ammonium carbonates and bicarbonates in anticorrosive coatings of metal substrates
JP2003517386A5 (enExample)
EP1895017A3 (en) Use of A33 antigens and JAM-IT
ATE442806T1 (de) Geschirrkorb einer geschirrspülmaschine
JP2009155453A5 (enExample)
MA27202A1 (fr) Composition pour le traitement de tissus comprenant un agent permettant d'ameliorer l'aspect de la solution de rincage
MY142971A (en) Supported metallocene-alkyl catalyst composition
EP1510168A3 (en) Wash arm arrangement for a dishwasher
JPH09235233A5 (enExample)
DE502004006869D1 (de) alpha-(1' -HYDROXYALKYL)ACRYLATE ENTHALTENDE BESCHICHTUNGSMASSEN
He et al. Analysis of air conditioning load prediction by modified seasonal exponential smoothing model
JPH116484A5 (enExample)
JP2003284553A5 (enExample)
JP2008505206A5 (enExample)
RU2007117299A (ru) Косметический или фармацевтический продукт для наружного применения на основе папайи
JP2005154579A5 (enExample)
RU2001113347A (ru) Буферная жидкость
CN107752667A (zh) 一种可悬挂在杯壁上的勺子